A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
Clinical trial NCT07001280 · RECRUITING
Trial details
- NCT number
- NCT07001280
- Sponsor
- CSL Behring
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-21
- Primary completion
- 2028-08-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.